Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Kenneth H Dinnon 3rd^#¹, Sarah R Leist^#², Alexandra Schäfer², Caitlin E Edwards², David R Martinez², Stephanie A Montgomery³, Ande West², Boyd L Yount Jr², Yixuan J Hou², Lily E Adams¹, Kendra L Gully², Ariane J Brown², Emily Huang², Matthew D Bryant⁴, Ingrid C Choong⁴, Jeffrey S Glenn^{5

6}, Lisa E Gralinski², Timothy P Sheahan², Ralph S Baric^{7

8

9}

Affiliations

¹ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
² Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
⁴ Eiger BioPharmaceuticals, Palo Alto, CA, USA.
⁵ Departments of Medicine and Microbiology and Immunology, Stanford University, Stanford, CA, USA.
⁶ Palo Alto Veterans Administration, Palo Alto, CA, USA.
⁷ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
⁸ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
⁹ Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill, NC, USA. rbaric@email.unc.edu.

^# Contributed equally.

PMID: 33469219
DOI: 10.1038/s41586-020-03107-5

Published Erratum

Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Kenneth H Dinnon 3rd et al. Nature. 2021 Feb.

. 2021 Feb;590(7844):E22.

doi: 10.1038/s41586-020-03107-5.

Authors

Affiliations

¹ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
² Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
³ Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
⁴ Eiger BioPharmaceuticals, Palo Alto, CA, USA.
⁵ Departments of Medicine and Microbiology and Immunology, Stanford University, Stanford, CA, USA.
⁶ Palo Alto Veterans Administration, Palo Alto, CA, USA.
⁷ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
⁸ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
⁹ Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill, NC, USA. rbaric@email.unc.edu.

^# Contributed equally.

PMID: 33469219
DOI: 10.1038/s41586-020-03107-5

No abstract available

PubMed Disclaimer

Erratum for

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Dinnon KH 3rd, Leist SR, Schäfer A, Edwards CE, Martinez DR, Montgomery SA, West A, Yount BL Jr, Hou YJ, Adams LE, Gully KL, Brown AJ, Huang E, Bryant MD, Choong IC, Glenn JS, Gralinski LE, Sheahan TP, Baric RS. Dinnon KH 3rd, et al. Nature. 2020 Oct;586(7830):560-566. doi: 10.1038/s41586-020-2708-8. Epub 2020 Aug 27. Nature. 2020. PMID: 32854108 Free PMC article.

Cited by

The signal pathways and treatment of cytokine storm in COVID-19.
Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. Yang L, et al. Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0. Signal Transduct Target Ther. 2021. PMID: 34234112 Free PMC article. Review.
Mouse Models for the Study of SARS-CoV-2 Infection.
Knight AC, Montgomery SA, Fletcher CA, Baxter VK. Knight AC, et al. Comp Med. 2021 Oct 1;71(5):383-397. doi: 10.30802/AALAS-CM-21-000031. Epub 2021 Oct 5. Comp Med. 2021. PMID: 34610856 Free PMC article. Review.
Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics.
Afzal M, Melnyk D, Courty T, Schimanski L, Hill M, Neil S, Tan TK, James WS. Afzal M, et al. iScience. 2025 Apr 16;28(6):112451. doi: 10.1016/j.isci.2025.112451. eCollection 2025 Jun 20. iScience. 2025. PMID: 40496810 Free PMC article.
Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice.
Yasui F, Matsumoto Y, Yamamoto N, Sanada T, Honda T, Munakata T, Itoh Y, Kohara M. Yasui F, et al. Sci Rep. 2022 Mar 9;12(1):4150. doi: 10.1038/s41598-022-08104-4. Sci Rep. 2022. PMID: 35264719 Free PMC article.
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
Rahman SM, Buchholz DW, Imbiakha B, Jager MC, Leach J, Osborn RM, Birmingham AO, Dewhurst S, Aguilar HC, Luebke AE. Rahman SM, et al. J Virol. 2024 Jul 23;98(7):e0006624. doi: 10.1128/jvi.00066-24. Epub 2024 May 30. J Virol. 2024. PMID: 38814068 Free PMC article.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Affiliations

Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Authors

Affiliations

Erratum for

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous